Metabolic syndrome linked to accelerated brain ageing: inflammation and vascular factors implicated

Summary

A study using UK Biobank data links metabolic syndrome, a cluster of five risk factors, to accelerated brain ageing. By estimating brain age from MRI markers in 27,375 adults, researchers found that the brain-age gap grows with each additional metabolic syndrome component, equating to about 1 year older brain for three components, 1.7 years for four, and 2.3 years for all five. Three metabolites GlycA, the ApoB/ApoA1 ratio, and specific fatty acids partly explain the relationship, likely through inflammation and reduced brain blood flow. All five components are modifiable through lifestyle changes, underscoring potential interventions to protect brain health. The Conversation is the original publisher.

• Brain-age gap grows with more metabolic syndrome components
• Three metabolites partly explain the link
• Even partial improvements can slow brain ageing
• All components are lifestyle-modifiable

Overview

Metabolic syndrome affects about one in four adults worldwide and represents a cluster of interrelated risk factors that collectively raise health risks. While it is well known as a warning sign for cardiovascular and metabolic diseases, emerging evidence from large datasets suggests its consequences extend to the brain, potentially accelerating ageing. The Conversation discusses a UK Biobank study that investigates how metabolic syndrome relates to brain ageing using the brain-age gap concept. This gap measures how old a brain appears relative to the person’s chronological age, derived from patterns in magnetic resonance imaging (MRI) scans and assessed with machine learning.

The central finding is striking: people with metabolic syndrome have brains that look older than their actual age, and the more components of the syndrome a person has, the larger the gap. This aligns with prior work linking metabolic health to neurological outcomes, including stroke, dementia and Parkinson’s disease, but the mechanism by which metabolic syndrome affects the brain remained unclear until now. The study uses a large, well-characterised dataset to delve into potential pathways and mediators that might explain this association.

Data and methods

Researchers analysed data from 27,375 study participants in the UK Biobank, a vast resource that tracks health and ageing in adults aged 40 to 70 as they age. Brain age was estimated using more than 1,000 imaging markers derived from MRI scans, which capture a range of brain features including brain tissue loss, white matter integrity, and vascular damage. A machine learning model was first trained on the scans of the healthiest participants, whose brain age should closely match their chronological age. The model then predicted brain age for the full study population. The brain-age gap was obtained by subtracting chronological age from the predicted brain age for each participant.

The five components of metabolic syndrome—high blood sugar, high blood pressure, excess abdominal fat, low HDL (“good”) cholesterol, and high triglycerides—were defined according to standard guidelines. Participants were grouped by how many components they had, and the researchers examined how the brain-age gap varied across these groups. In addition, the study probed blood metabolites to explore possible mechanisms linking metabolic syndrome to brain ageing, focusing on GlycA, ApoB/ApoA1 ratio and fatty acids, including omega-6 fatty acids.

Key findings

• The results showed that metabolic syndrome components are systematically associated with an older-looking brain. The more components a person has, the larger the brain-age gap.
• Specifically, individuals with three components had brains that appeared about one year older than their chronological age on average; four components corresponded to a 1.7-year gap; and all five components were linked to a 2.3-year gap.
• Each metabolic syndrome component was independently associated with an older-looking brain, suggesting a cumulative effect across the syndrome’s risk factors.

Biological pathways and mediators

To understand why metabolic syndrome might accelerate brain ageing, the researchers examined blood samples collected at baseline for hundreds of metabolites. Three metabolites emerged as partial mediators of the link between metabolic syndrome and brain ageing.

• GlycA, a marker of chronic, low-grade inflammation. Higher GlycA levels in people with metabolic syndrome point to systemic inflammation that could damage brain blood vessels and promote harmful processes in the brain.
• The ApoB/ApoA1 ratio, markers of atherosclerosis. Higher ApoB relative to ApoA1 indicates more atherosclerotic risk and reduced cerebral blood flow, potentially depriving brain tissue of oxygen and nutrients.
• Fatty acids, including omega-6 and other polyunsaturated fats, which are abundant in the brain and essential for cell structure and function. Alterations in fatty acid profiles may influence brain cell membranes and signaling.

These metabolites offer plausible biological mechanisms by which metabolic syndrome could drive accelerated brain ageing, through vascular damage, inflammatory processes, and alterations in brain cellular components. Importantly, these are not claimed to be the sole mediators, but rather partial explanatory pathways supported by the data.

Implications for brain health and interventions

A key takeaway is that all five components of metabolic syndrome are modifiable through everyday lifestyle choices such as regular physical activity, a balanced diet and adequate sleep. The study’s authors note that even partial improvements—reducing the number or severity of components—could meaningfully slow the pace of brain ageing. While brain ageing is a natural process, its rate is not immutable, and metabolic health appears to be a lever that can influence how quickly the brain ages. The findings add to a growing body of evidence linking cardiovascular, metabolic and inflammatory health to cognitive health and brain resilience in ageing.

Limitations and future directions

As an observational analysis, the study cannot prove causation between metabolic syndrome and brain ageing. While the statistical associations and mediating metabolites are compelling, causal inferences require further investigation, potentially including longitudinal analyses and interventional trials that target metabolic syndrome components to determine their effects on brain ageing directly.

Concluding remarks

The work highlights a broader perspective on metabolic syndrome, showing that its consequences extend beyond cardiovascular risk to the brain itself. Maintaining metabolic health has potential benefits for brain ageing and cognitive health, reinforcing public health messages about the importance of exercise, nutrition and sleep for overall wellbeing.

Author: The Conversation